GS JT (Votrient pazopanib 200 mg)

Generic Name: pazopanib

Pill imprint GS JT has been identified as Votrient pazopanib 200 mg.

Votrient is used in the treatment of renal cell carcinoma; soft tissue sarcoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GS JT (Votrient pazopanib 200 mg)

Votrient pazopanib 200 mg GS JT
Votrient
Generic Name:
pazopanib
Imprint:
GS JT
Strength:
pazopanib 200 mg
Color:
Gray
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0804
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
hypromelloses
ferrosoferric oxide
polyethylene glycol 400
polysorbate 80
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)